Raia Drogasil SA (RADLY)
4.99
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Raia Drogasil Debt to Equity Ratio: 0.4677 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.4677 |
December 31, 2023 | 0.5256 |
September 30, 2023 | 0.5426 |
June 30, 2023 | 0.4345 |
March 31, 2023 | 0.417 |
December 31, 2022 | 0.434 |
September 30, 2022 | 0.4483 |
June 30, 2022 | 0.4726 |
March 31, 2022 | 0.4565 |
December 31, 2021 | 0.3218 |
September 30, 2021 | 0.3293 |
June 30, 2021 | 0.3337 |
March 31, 2021 | 0.3692 |
December 31, 2020 | 0.379 |
September 30, 2020 | 0.415 |
June 30, 2020 | 0.4253 |
March 31, 2020 | 0.3443 |
December 31, 2019 | 0.2799 |
September 30, 2019 | 0.3122 |
June 30, 2019 | 0.2758 |
March 31, 2019 | 0.3051 |
December 31, 2018 | 0.2409 |
September 30, 2018 | 0.2684 |
June 30, 2018 | 0.2775 |
March 31, 2018 | 0.1794 |
Date | Value |
---|---|
December 31, 2017 | 0.1896 |
September 30, 2017 | 0.2329 |
June 30, 2017 | 0.2516 |
March 31, 2017 | 0.163 |
December 31, 2016 | 0.1423 |
September 30, 2016 | 0.128 |
June 30, 2016 | 0.1178 |
March 31, 2016 | 0.1116 |
December 31, 2015 | 0.1125 |
September 30, 2015 | 0.0991 |
June 30, 2015 | 0.1044 |
March 31, 2015 | 0.1022 |
December 31, 2014 | 0.1145 |
September 30, 2014 | 0.0923 |
June 30, 2014 | 0.1037 |
March 31, 2014 | 0.1107 |
December 31, 2013 | 0.1052 |
September 30, 2013 | 0.0797 |
June 30, 2013 | 0.0842 |
March 31, 2013 | 0.0887 |
December 31, 2012 | 0.0849 |
September 30, 2012 | 0.0661 |
June 30, 2012 | 0.0734 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.0737 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2758
Minimum
Jun 2019
0.5426
Maximum
Sep 2023
0.3992
Average
0.416
Median
Debt to Equity Ratio Benchmarks
Hypera SA | 0.906 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.5332 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.116B |
Total Liabilities (Quarterly) | 2.891B |
Shareholders Equity (Quarterly) | 1.210B |
Current Ratio | 1.434 |
Net Debt Paydown Yield | -0.30% |